Engineered platelets deliver immunotherapy – Nature.com
|
Engineered platelets deliver immunotherapy
Nature.com Immunotherapeutic strategies, such as anti-programmed cell death protein (PD1) therapy, can prevent post-surgical cancer recurrence, but their use can be limited by off-target effects. Given that platelets migrate to surgical sites and can interact … |
